And this may bring some partners knocking when the patent is officially announced (on Tuesday)?
ANAVEX 2-73 also shows synergistic activity with three generations of epilepsy drugs currently on the market: ETS (Zaronin®), VPA (Depakene®) and Gabapenin (Neuronin®)